(A) Direct ELISA of trastuzumab and 13 against HER2 extracellular domain. active mimic binds to cells with a 10-fold lower avidity than the least active variant suggesting that structure plays a large role in their efficacy. This work suggests that the megamolecule approach can be used to prepare antibody mimics having a broad structural diversity. […]